C Zheng, I Kar, CK Chen, C Sau, S Woodson, A Serra… - CNS drugs, 2020 - Springer
Abstract The coronavirus 2019 (COVID-19) pandemic is expected to linger. Decisions
regarding initiation or continuation of disease-modifying therapy for multiple sclerosis have …